Weak androgen levels, glucocorticoid therapy, and bone mineral density in postmenopausal women with rheumatoid arthritis.

Fiter, J; Nolla, J M; Navarro, M A; Gómez-Vaquero, C; Rosel, P; Mateo, L; Roig-Escofet, D

Fiter, J; Nolla, J M; Navarro, M A; Gómez-Vaquero, C; Rosel, P; Mateo, L; Roig-Escofet, D.

Affiliation

Fiter J; Rheumatology department, Prínceps d'Espanya Hospital, ciutat sanitària i universitària de Bellvitge, Barcelona, Spain.

Joint Bone Spine ; 67(3): 199-203, 2000.

Article in En | MEDLINE | ID: mdl-10875318

Subject(s)

Androgens/blood; Arthritis, Rheumatoid/blood; Arthritis, Rheumatoid/drug therapy; Bone Density/drug effects; Glucocorticoids/adverse effects; Postmenopause/drug effects; Postmenopause/physiology; Androstenedione/blood; Arthritis, Rheumatoid/physiopathology; Bone Density/physiology; Dehydroepiandrosterone Sulfate/blood; Female; Glucocorticoids/administration & dosage; Humans; Middle Aged; Osteoporosis/chemically induced; Osteoporosis/physiopathology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Arthritis, Rheumatoid / Bone Density / Postmenopause / Glucocorticoids / Androgens Limits: Female / Humans / Middle aged Language: En Year: 2000 Type: Article

Search on Google

XML

PubMed Links